Genomic-scale prioritization of disease-related non-coding RNAs

0Citations
Citations of this article
2Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The recent explosion in the number and diversity of non-coding RNAs (ncRNAs) identified by the large-scale technologies brings new challenges to the biomedical researchers – What are all these non-coding RNAs, how did they work, and most importantly, what is the relationship between them and complex diseases? Although some ncRNAs have been clearly characterized as risk biomarkers through biological experiments, there are still a limit number of known disease associated ncRNAs. Thus, bioinformatics methods have been widely used to predict candidate ncRNAs and disease associations. In this chapter, we will discuss several bioinformatics methods which have been developed to predict novel non-coding biomarkers. With such methods and tools, the prioritization and identification of complex-implicated ncRNAs is becoming a reality.

Cite

CITATION STYLE

APA

Wang, P., & Li, X. (2018). Genomic-scale prioritization of disease-related non-coding RNAs. In Advances in Experimental Medicine and Biology (Vol. 1094, pp. 29–37). Springer New York LLC. https://doi.org/10.1007/978-981-13-0719-5_4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free